Tech Company Financing Transactions
Celladon Funding Round
Celladon closed a $6.6 million funding round on 3/31/2009. Backers included Enterprise Partners Venture Capital and Venrock.
Transaction Overview
Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$6,608,000
Round
Undisclosed
Investors
Enterprise Partners Venture Capital (Drew Senyei)
Venrock (Anthony Evnin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12760 High Bluff Dr. 240
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Celladon Corporation is an exciting new biotechnology company focused on developing treatments for cardiovascular diseases through the application of scientific discoveries in molecular cardiology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Krisztina Zsebo
VP - Finance
Rebecque Laba
VP - General Counsel
Elizabeth Reed
VP - Operations
Jeffrey Rudy
Browse more venture capital transactions:
Prev: 3/31/2009: Limbo 41414 venture capital transaction
Next: 3/31/2009: Vidder venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs